UK markets open in 4 hours 31 minutes
NIKKEI 225
27,062.57 +70.36 (+0.26%) HANG SENG
17,844.81 +765.30 (+4.48%) CRUDE OIL
86.03 -0.49 (-0.57%) GOLD FUTURES
1,728.80 -1.70 (-0.10%) DOW
30,316.32 +825.43 (+2.80%) BTC-GBP
17,704.20 +539.26 (+3.14%)
WuXi Biologics (Cayman) Inc. (2269.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
As of 10:14AM HKT. Market open.
Currency in HKD
Valuation measures4
| Market cap (intra-day) | 202.09B |
| Enterprise value | 196.07B |
| Trailing P/E | 46.82 |
| Forward P/E | 25.91 |
| PEG ratio (5-yr expected) | 0.69 |
| Price/sales (ttm) | 14.67 |
| Price/book (mrq) | 5.39 |
| Enterprise value/revenue | 14.98 |
| Enterprise value/EBITDA | 39.97 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.89 |
| 52-week change 3 | -58.22% |
| S&P500 52-week change 3 | -13.12% |
| 52-week high 3 | 121.500 |
| 52-week low 3 | 40.300 |
| 50-day moving average 3 | 64.195 |
| 200-day moving average 3 | 67.513 |
Share statistics
| Avg vol (3-month) 3 | 21.32M |
| Avg vol (10-day) 3 | 20.81M |
| Shares outstanding 5 | 4.26B |
| Implied shares outstanding 6 | N/A |
| Float 8 | 3.54B |
| % held by insiders 1 | 15.44% |
| % held by institutions 1 | 47.70% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 3:1 |
| Last split date 3 | 16 Nov 2020 |
Financial highlights
Currency in CNY.Fiscal year
| Fiscal year ends | 31 Dec 2021 |
| Most-recent quarter (mrq) | 30 Jun 2022 |
Profitability
| Profit margin | 31.18% |
| Operating margin (ttm) | 30.66% |
Management effectiveness
| Return on assets (ttm) | 5.51% |
| Return on equity (ttm) | 12.30% |
Income statement
| Revenue (ttm) | 13.09B |
| Revenue per share (ttm) | 3.13 |
| Quarterly revenue growth (yoy) | 63.50% |
| Gross profit (ttm) | 4.83B |
| EBITDA | 4.6B |
| Net income avi to common (ttm) | 4.08B |
| Diluted EPS (ttm) | 1.040 |
| Quarterly earnings growth (yoy) | 37.60% |
Balance sheet
| Total cash (mrq) | 9.86B |
| Total cash per share (mrq) | 2.36 |
| Total debt (mrq) | 4.4B |
| Total debt/equity (mrq) | 12.40 |
| Current ratio (mrq) | 2.30 |
| Book value per share (mrq) | 8.25 |
Cash flow statement
| Operating cash flow (ttm) | 4.09B |
| Levered free cash flow (ttm) | -1.32B |
© 2022 Yahoo. All rights reserved.
